PubMed Systematic reviewGLP-1 class evidence2025 Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons
Mounjaro isn't approved by the FDA to treat obesity, but studies have found that higher doses of tirzepatide (the active ingredient in Mounjaro) can cause significant weight loss
Furthermore, it has been demonstrated that oxyntomodulin is capable of inhibiting the activation of the NF-B pathway in the spinal cord (Zhang et al., 2019)
ACS Sustain Chem Eng 6(2):21882196 Sun Y, Lin Y, Sun W, Han R, Luo C, Wang X, Wei Q (2019) A highly selective and sensitive detection of insulin with chemiluminescence biosensor based on aptamer and oligonucleotide-AuNPs functionalized nanosilica@graphene oxide aerogel
Getting to this diagnosis takes time and careful thinking